======= DPM3 ======= == Gene Information == * **Official Symbol**: DPM3 * **Official Name**: dolichyl-phosphate mannosyltransferase subunit 3, regulatory * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54344|54344]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P2X0|Q9P2X0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DPM3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPM3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605951|Open OMIM]] == Function Summary == * **Entrez Summary**: Dolichol-phosphate mannose (Dol-P-Man) serves as a donor of mannosyl residues on the lumenal side of the endoplasmic reticulum (ER). Lack of Dol-P-Man results in defective surface expression of GPI-anchored proteins. Dol-P-Man is synthesized from GDP-mannose and dolichol-phosphate on the cytosolic side of the ER by the enzyme dolichyl-phosphate mannosyltransferase. The protein encoded by this gene is a subunit of dolichyl-phosphate mannosyltransferase and acts as a stabilizer subunit of the dolichyl-phosphate mannosyltransferase complex. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Stabilizer subunit of the dolichol-phosphate mannose (DPM) synthase complex; tethers catalytic subunit DPM1 to the ER. {ECO:0000269|PubMed:10835346}. |DPM3| |mannosyltransferase complex| |dolichol-phosphate-mannose synthase complex| |dolichyl-phosphate beta-D-mannosyltransferase activity| |peptidyl-tryptophan modification| |protein C-linked glycosylation via 2-alpha-mannosyl-L-tryptophan| |protein C-linked glycosylation via tryptophan| |protein C-linked glycosylation| |protein O-linked mannosylation| |protein mannosylation| |GPI anchor biosynthetic process| |GPI anchor metabolic process| |protein N-linked glycosylation via asparagine| |peptidyl-asparagine modification| |mannosylation| |glycolipid biosynthetic process| |protein N-linked glycosylation| |protein lipidation| |lipoprotein biosynthetic process| |integral component of endoplasmic reticulum membrane| |glycolipid metabolic process| |phosphatidylinositol biosynthetic process| |liposaccharide metabolic process| |protein O-linked glycosylation| |lipoprotein metabolic process| |membrane lipid biosynthetic process| |phosphatidylinositol metabolic process| |membrane lipid metabolic process| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |phospholipid biosynthetic process| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |regulation of protein stability| |glycerophospholipid metabolic process| |glycoprotein biosynthetic process| |phospholipid metabolic process| |glycerolipid metabolic process| |glycoprotein metabolic process| |carbohydrate metabolic process| |organophosphate biosynthetic process| |lipid biosynthetic process| |carbohydrate derivative biosynthetic process| |peptidyl-amino acid modification| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |endoplasmic reticulum| |carbohydrate derivative metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-2.36| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|1.77| ^Gene^Correlation^ |[[:human genes:a:alg9|ALG9]]|0.633| |[[:human genes:a:alg6|ALG6]]|0.539| |[[:human genes:m:mpdu1|MPDU1]]|0.531| |[[:human genes:d:dpm1|DPM1]]|0.53| |[[:human genes:a:alg3|ALG3]]|0.53| |[[:human genes:s:sec62|SEC62]]|0.493| |[[:human genes:s:sec63|SEC63]]|0.492| |[[:human genes:d:dhrsx|DHRSX]]|0.48| |[[:human genes:a:alg5|ALG5]]|0.463| |[[:human genes:m:mbtps2|MBTPS2]]|0.451| |[[:human genes:d:dnajc3|DNAJC3]]|0.448| |[[:human genes:s:srd5a3|SRD5A3]]|0.438| |[[:human genes:c:cbfb|CBFB]]|0.435| |[[:human genes:a:alg12|ALG12]]|0.433| |[[:human genes:a:alg8|ALG8]]|0.427| |[[:human genes:m:manf|MANF]]|0.421| |[[:human genes:d:dpagt1|DPAGT1]]|0.417| |[[:human genes:a:alg1|ALG1]]|0.417| |[[:human genes:c:chka|CHKA]]|0.409| |[[:human genes:d:dolk|DOLK]]|0.408| |[[:human genes:u:ugp2|UGP2]]|0.407| |[[:human genes:a:atp2a2|ATP2A2]]|0.406| |[[:human genes:d:dnajb11|DNAJB11]]|0.403| |[[:human genes:p:pmm2|PMM2]]|0.4| |[[:human genes:t:trmt61a|TRMT61A]]|0.4| Global Fraction of Cell Lines Where Essential: 6/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|3/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5159 * **Expression level (log2 read counts)**: 2.56 {{:chemogenomics:nalm6 dist.png?nolink |}}